QTTB Stock Analysis: Buy, Sell, or Hold?
QTTB - Q32 Bio Inc. Common Stock
$21.38
10.17 (90.72%)
β²
5d:
+66.19%
30d:
+66.12%
90d:
+323.37%
WAIT
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 05, 2026
22d
Get Alerted When QTTB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR BETTER ENTRY: QTTB is 43.9% above its trading range ($14.86). While momentum could continue, risk/reward favors waiting for a pullback.
βΈοΈ WAIT FOR BETTER ENTRY: QTTB is 43.9% above its trading range ($14.86). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: QTTB is currently trading at $21.38, which is considered extended relative to its 30-day fair value range of $11.20 to $14.86.
Technical Outlook: Technically, QTTB is in a uptrend. The price is approaching resistance at $14.85. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 90.7% recently.
Market Sentiment: QTTB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $14.25. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, QTTB is in a uptrend. The price is approaching resistance at $14.85. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 90.7% recently.
Market Sentiment: QTTB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $14.25. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$11.20 -
$14.86
Company Quality Score
40/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.4%
All Signals
- BEARISH: Price significantly overextended (+43.9% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+90.7%)
- BEARISH: Trading 33.3% above Wall St target ($14.25)
- WARNING: Recommendation downgraded due to 43.9% overvaluation
Trading Range Analysis
30-Day Trading Range
$11.20 -
$14.86
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$9.15
Resistance Level
$14.85
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.59
Wall Street Target
$14.25
(-33.3%)
Profit Margin
61.9%
Share & Embed Analysis
Last updated: July 13, 2026 6:01 PM ET
Data refreshes hourly during market hours. Next update: 7:01 PM
Data refreshes hourly during market hours. Next update: 7:01 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QTTB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Jodie Pope Morrison
SELL
9896 shares
2026-02-25
Lee Kalowski
SELL
3995 shares
2026-02-25
Shelia M Violette
SELL
2815 shares
2026-02-25
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$258 | 67 BUY |
|
DNTH
Dianthus Therapeutics In⦠|
STRONG BUY
12 analysts |
$128 | 59 HOLD |
|
BEAM
Beam TherapeuticsΒ Inc |
STRONG BUY
17 analysts |
$51 | 49 HOLD |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 54 HOLD |
|
XNCR
Xencor Inc |
STRONG BUY
12 analysts |
$28 | 61 BUY |